According to SurModics's latest financial reports the company's current EPS (TTM) is -$1.65. In 2022 the company made an earnings per share (EPS) of -$2.32 a decrease over its 2021 EPS that were of $0.13.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.65 | -28.88% |
2022 | -$2.32 | -1884.62% |
2021 | $0.13 | 160% |
2020 | $0.05000 | -89.58% |
2019 | $0.48 | -536.36% |
2018 | -$0.11 | |
2017 | N/A | -100% |
2016 | $0.73 | -23.16% |
2015 | $0.95 | 7.95% |
2014 | $0.88 | -13.73% |
2013 | $1.02 | 41.67% |
2012 | $0.72 | -228.57% |
2011 | -$0.56 | -57.89% |
2010 | -$1.33 | -290% |
2009 | $0.70 | -65.69% |
2008 | $2.04 | 1100% |
2007 | $0.17 | -84.26% |
2006 | $1.08 | -370% |
2005 | -$0.40 | -180% |
2004 | $0.50 | -45.05% |
2003 | $0.91 | 82% |
2002 | $0.50 | 21.95% |
2001 | $0.41 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $14.09 | -953.65% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $2.97 | -280.13% | ๐บ๐ธ USA |
Thermo Fisher Scientific TMO | $15.34 | -1,029.70% | ๐บ๐ธ USA |
Agilent Technologies A | $3.83 | -332.12% | ๐บ๐ธ USA |
PerkinElmer
PKI | $7.70 | -566.65% | ๐บ๐ธ USA |
Alkermes ALKS | $1.30 | -178.79% | ๐ฎ๐ช Ireland |
Nektar Therapeutics
NKTR | -$1.63 | -1.21% | ๐บ๐ธ USA |
Heron Therapeutics HRTX | -$1.17 | -29.09% | ๐บ๐ธ USA |
Enzo Biochem ENZ | -$0.94 | -43.03% | ๐บ๐ธ USA |